Medicare Enrolled

Dr. Sara Tolaney, MD

Internal Medicine · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
55 FRUIT STREET YAW 7604, Boston, MA 02114
6177262782
In practice since 2005 (20 years)
NPI: 1962487330 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tolaney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tolaney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tolaney

Dr. Sara Tolaney is an internal medicine specialist in Boston, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tolaney performed 92 Medicare services across 39 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tolaney received a total of $675,582 from 41 pharmaceutical and/or device companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tolaney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 92 Medicare services $675,582 industry payments

Medicare Practice Summary

Medicare Utilization ↗
92
Medicare services
Bottom 13% in MA for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
39
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
 92 $119 $727
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$675,582
Total received (2018-2024)
Avg $96,512/year across 7 years
Top 0% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
446
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$575,775 (85.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$75,423 (11.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,384 (3.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$184,231
2023
$103,682
2022
$89,437
2021
$102,281
2020
$81,267
2019
$54,146
2018
$60,539

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$36,468
Gilead Sciences, Inc.
$29,949
AstraZeneca UK Limited
$20,358
JAZZ PHARMACEUTICALS INC.
$20,246
AstraZeneca Pharmaceuticals LP
$12,027
Daiichi Sankyo Inc.
$11,081
Stemline Therapeutics Inc.
$10,344
Genentech, Inc.
$7,482
BioNTech SE
$6,853
Lilly USA, LLC
$5,850
Genentech USA, Inc.
$4,982
Eli Lilly and Company
$4,500
E.R. Squibb & Sons, L.L.C.
$4,254
F. Hoffmann-La Roche AG
$3,824
Novartis Pharmaceuticals Corporation
$3,613
Janssen Research & Development, LLC
$2,400
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$101,431
Eli Lilly and Company
$72,438
PFIZER INC.
$68,962
AstraZeneca Pharmaceuticals LP
$56,033
AstraZeneca UK Limited
$46,469
Novartis Pharmaceuticals Corporation
$43,650
Merck Sharp & Dohme Corporation
$26,839
F. Hoffmann-La Roche AG
$26,379
JAZZ PHARMACEUTICALS INC.
$20,246
Lilly USA, LLC
$19,553
Daiichi Sankyo Inc.
$19,070
E.R. Squibb & Sons, L.L.C.
$17,257
Genentech, Inc.
$16,633
Stemline Therapeutics Inc.
$14,338
GENZYME CORPORATION
$13,655
Genentech USA, Inc.
$12,835
Puma Biotechnology, Inc.
$9,938
Seagen Inc.
$9,737
SANOFI-AVENTIS U.S. LLC
$8,352
SANOFI US SERVICES INC.
$7,346
BioNTech SE
$6,853
Eisai Inc.
$5,372
Eisai Co., Ltd.
$5,275
EISAI INC.
$4,803
Daiichi Sankyo Company LTD
$4,375
Bayer HealthCare Pharmaceuticals Inc.
$4,278
Merck Sharp & Dohme LLC
$4,270
Athenex Pharmaceutical Division, LLC
$3,900
Immunomedics, Inc.
$3,850
Incyte Corporation
$3,075
Janssen Research & Development, LLC
$2,400
NOVARTIS PHARMACEUTICALS CORPORATION
$2,362
TerSera Therapeutics LLC
$2,085
Kyowa Kirin, Inc.
$2,000
Chugai Pharmaceutical Co., Ltd.
$1,980
Myovant Sciences Inc.
$1,938
Blueprint Medicines Corporation
$1,850
Samsung Bioepis Co., Ltd.
$1,750
TESARO, Inc.
$1,711
Aadi Bioscience, Inc.
$250
Roche Products Limited
$43
Top 3 companies account for 35.9% of all-time payments
Associated products mentioned in payments ›
BYL719 · CYRAMZA · ENHERTU · Enhertu · FYARRO · Halaven · IBRANCE · IMFINZI · KEYTRUDA · KISQALI · Kadcyla · LYNPARZA · Lenvima · NO PRODUCT DISCUSSED · Nerlynx · Non-Covered Product · ONTRUZANT · OPDIVO · Oral Paclitaxel · Orserdu · PIQRAY · Perjeta · Phesgo · SAR439859 · TALZENNA · TECENTRIQ · TRODELVY · TUKYSA · Trodelvy · VERZENIO · Vitrakvi · ZEJULA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for internal medicine in MA.

Looking for an internal medicine specialist in Boston?
Compare internal medicine physicians in the Boston area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
5,615
Per 100K population
717.9
County median income
$92,859
Nearest hospital
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tolaney is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 0% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tolaney experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Tolaney performed 92 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tolaney receive payments from pharmaceutical companies?
Yes. Dr. Tolaney received a total of $675,582 from 41 companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tolaney's costs compare to other internal medicine physicians in Boston?
Dr. Tolaney's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tolaney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Internal Medicine Physicians in Boston
Browse internal medicine physicians in Boston ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MA
Which MA internal medicine physicians receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →